JP2020512348A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020512348A5 JP2020512348A5 JP2019553023A JP2019553023A JP2020512348A5 JP 2020512348 A5 JP2020512348 A5 JP 2020512348A5 JP 2019553023 A JP2019553023 A JP 2019553023A JP 2019553023 A JP2019553023 A JP 2019553023A JP 2020512348 A5 JP2020512348 A5 JP 2020512348A5
- Authority
- JP
- Japan
- Prior art keywords
- biomolecule
- radiolabeled
- group
- substituted
- radiolabeled biomolecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023062556A JP2023076712A (ja) | 2017-03-30 | 2023-04-07 | 放射標識生体分子およびその使用 |
| JP2025027120A JP2025071280A (ja) | 2017-03-30 | 2025-02-21 | 放射標識生体分子およびその使用 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762478754P | 2017-03-30 | 2017-03-30 | |
| US62/478,754 | 2017-03-30 | ||
| US201762500692P | 2017-05-03 | 2017-05-03 | |
| US62/500,692 | 2017-05-03 | ||
| US201762529532P | 2017-07-07 | 2017-07-07 | |
| US62/529,532 | 2017-07-07 | ||
| US201762583134P | 2017-11-08 | 2017-11-08 | |
| US62/583,134 | 2017-11-08 | ||
| PCT/IB2018/052211 WO2018178936A1 (en) | 2017-03-30 | 2018-03-29 | Radiolabeled biomolecules and their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023062556A Division JP2023076712A (ja) | 2017-03-30 | 2023-04-07 | 放射標識生体分子およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020512348A JP2020512348A (ja) | 2020-04-23 |
| JP2020512348A5 true JP2020512348A5 (cg-RX-API-DMAC7.html) | 2021-05-06 |
Family
ID=62017598
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553023A Withdrawn JP2020512348A (ja) | 2017-03-30 | 2018-03-29 | 放射標識生体分子およびその使用 |
| JP2023062556A Withdrawn JP2023076712A (ja) | 2017-03-30 | 2023-04-07 | 放射標識生体分子およびその使用 |
| JP2025027120A Pending JP2025071280A (ja) | 2017-03-30 | 2025-02-21 | 放射標識生体分子およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023062556A Withdrawn JP2023076712A (ja) | 2017-03-30 | 2023-04-07 | 放射標識生体分子およびその使用 |
| JP2025027120A Pending JP2025071280A (ja) | 2017-03-30 | 2025-02-21 | 放射標識生体分子およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20200188541A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3600453A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2020512348A (cg-RX-API-DMAC7.html) |
| CN (1) | CN110709106A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018178936A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102899941B1 (ko) | 2019-05-24 | 2025-12-16 | 듀크 유니버시티 | 18f-방사선 표지된 생체 분자 |
| EP4058423A1 (en) | 2019-11-13 | 2022-09-21 | Duke University | Radiohalogen prosthetic moieties and radiolabeled biomolecules |
| EP3967674A1 (en) * | 2020-09-11 | 2022-03-16 | Precirix N.V. | Reactions of radioactive compounds facilitated by a solid phase |
| EP4337265A4 (en) * | 2021-05-14 | 2026-03-25 | Purdue Research Foundation | TARGETED FOLATE RECEPTOR CONJUGATIONS WITH BRUSH-ON ENZYME-CLEVABLE BINDERS AND METHODS OF USE IN CANCER IMAGING AND TREATMENT |
| KR20240095178A (ko) * | 2021-09-01 | 2024-06-25 | 듀크 유니버시티 | 단백질을 방사성 할로겐으로 부위-특이적 표지하기 위한 시약 및 이의 제조방법 및 사용 방법 |
| AU2023276697A1 (en) | 2022-05-23 | 2024-12-12 | Cereius, Inc. | Her2-binding agents and uses thereof |
| CN118388451A (zh) * | 2024-06-28 | 2024-07-26 | 四川大学 | 一种放射性标记的成纤维细胞活化蛋白抑制剂及其制备方法和应用 |
| WO2026128025A2 (en) | 2024-07-03 | 2026-06-18 | Solve Therapeutics, Inc. | Anti-ror2 antibody-radionuclide conjugates |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US5302700A (en) | 1988-05-23 | 1994-04-12 | Duke University | Radiohalogenation conjugate technology |
| FI903489A7 (fi) | 1988-11-11 | 1990-07-10 | Medical Res Council | Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| US7696320B2 (en) | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
| NZ540194A (en) | 2002-11-08 | 2008-07-31 | Ablynx Nv | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| CA2634666C (en) * | 2005-12-22 | 2015-05-26 | Duke University | Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters |
| EP2247615B1 (en) | 2008-02-14 | 2014-07-30 | Bristol-Myers Squibb Company | Targeted therapeutics based on engineered proteins that bind egfr |
| KR101389166B1 (ko) | 2011-01-12 | 2014-04-24 | 미쯔비시 레이온 가부시끼가이샤 | 활성 에너지선 경화성 수지 조성물, 미세 요철 구조체 및 미세 요철 구조체의 제조 방법 |
| KR101279584B1 (ko) | 2011-06-24 | 2013-06-28 | 대한민국 (식품의약품안전처장) | Erbb2 수용체에 선택적으로 결합하는 압타머 및 이의 용도 |
| EP2991687A4 (en) * | 2013-05-02 | 2016-11-09 | Univ Duke | PROSTHETIC COMPOUNDS FOR MARKING INTERNALIZING BIOMOLECULES |
| JP6289733B2 (ja) * | 2014-07-29 | 2018-03-07 | フレイエ ユニヴェルシテイト ブリュッセルVrije Universiteit Brussel | 癌の予防及び/又は治療に用いるための放射標識抗体断片 |
-
2018
- 2018-03-29 JP JP2019553023A patent/JP2020512348A/ja not_active Withdrawn
- 2018-03-29 EP EP18718637.4A patent/EP3600453A1/en active Pending
- 2018-03-29 CN CN201880036082.1A patent/CN110709106A/zh active Pending
- 2018-03-29 US US16/498,264 patent/US20200188541A1/en not_active Abandoned
- 2018-03-29 WO PCT/IB2018/052211 patent/WO2018178936A1/en not_active Ceased
-
2023
- 2023-04-07 JP JP2023062556A patent/JP2023076712A/ja not_active Withdrawn
-
2024
- 2024-11-13 US US18/946,772 patent/US20250073359A1/en active Pending
-
2025
- 2025-02-21 JP JP2025027120A patent/JP2025071280A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6533222B2 (ja) | 新規の抗体−薬剤コンジュゲート及び治療におけるその使用 | |
| JP7381478B2 (ja) | 単一分子量ポリサルコシンを含むリガンド-薬物-複合体 | |
| IL295571A (en) | Fibroblast activation protein ligands for targeted delivery applications | |
| TWI850308B (zh) | 包含配位子、間隔區、胜肽連接子及生物分子之複合體 | |
| JP6096371B2 (ja) | ビオチン改変体、ストレプトアビジン変異体およびそれらの利用 | |
| US20160303247A1 (en) | Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods | |
| AU2018317859A1 (en) | 6-amino-7,9-dihydro-8h-purin-8-one derivatives as immunostimulant Toll-like receptor 7 (TLR7) agonists | |
| EP3668871A1 (en) | 6-amino-7,9-dihydro-8h-purin-8-one derivatives as immunostimulant toll-like receptor 7 (tlr7) agonists | |
| EP3668868A1 (en) | Toll-like receptor 7 (tlr7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor | |
| JP2014516993A5 (cg-RX-API-DMAC7.html) | ||
| RU2015119557A (ru) | Конъюгаты лекарственное вещество-белок | |
| US11667724B2 (en) | Anti-human CEACAM5 antibody Fab fragment | |
| KR20130132935A (ko) | Nota에 의해 복합체를 형성한 알루미늄―〔18〕플루오라이드로 표지된 her2 결합 펩티드 | |
| US12202908B2 (en) | Complex having anti-human MUC1 antibody Fab fragment, peptide linker and/or ligand | |
| US20250073359A1 (en) | Radiolabeled biomolecules and their use | |
| JP2019534706A5 (cg-RX-API-DMAC7.html) | ||
| KR20130132939A (ko) | 18f - 함유 유기실리콘 화합물로 표지된 her2 결합 펩티드 | |
| JP2020524669A (ja) | 抗globo h抗体を含有する抗体−薬物コンジュゲートおよびその使用 | |
| JP2025503493A5 (cg-RX-API-DMAC7.html) | ||
| EP3727465A2 (en) | Transition metal-based functional moieties for preparing cell targeting conjugates | |
| US7205385B2 (en) | Polymerization method for the synthesis of polypeptide imaging agents | |
| JP2022518598A5 (cg-RX-API-DMAC7.html) | ||
| RU2007118385A (ru) | Контрастные агенты для направлений доставки во внеклеточный матрикс | |
| JP2025161882A (ja) | 放射性ハロゲン補欠部分および放射標識生体分子 | |
| NL2020120B1 (en) | Methods for preparing cell targeting conjugates and conjugates obtainable by said methods |